Processing

Please wait...

PATENTSCOPE will be unavailable a few hours for maintenance reason on Tuesday 25.01.2022 at 9:00 AM CET
Settings

Settings

Goto Application

1. WO2021102161 - METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE

Publication Number WO/2021/102161
Publication Date 27.05.2021
International Application No. PCT/US2020/061322
International Filing Date 19.11.2020
IPC
A61K 31/505 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
495having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
A61K 31/437 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
4353ortho- or peri-condensed with heterocyclic ring systems
437the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
A61P 13/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
13Drugs for disorders of the urinary system
CPC
A61K 31/437
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
4353ortho- or peri-condensed with heterocyclic ring systems
437the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
A61P 1/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1Drugs for disorders of the alimentary tract or the digestive system
Applicants
  • ANGION BIOMEDICA CORP. [US]/[US]
Inventors
  • PAKA, Swarnalatha
Agents
  • D'AMATO, Erica M.
  • ADAMS, Melissa M.
  • ADATO, Ronen
  • AUGST, Alexander D.
  • BUTEAU, Kristen C.
  • BYCHOWSKI, Meaghan E.
  • DAUKSS, Dana M.
  • FLYNN, Peter A.
  • HAULBROOK, William R.
  • JARRELL, Brenda Herschbach
  • LI, Xiaodong
  • LYON, Charles E.
  • MA, Longle
  • MEDINA, Rolando
  • MONROE, Margo R.
  • PACE, Nicholas J.
  • POLIO, Samuel R.
  • REARICK, John P.
  • REESE, Brian E.
  • SCHMITT, Michael D.
  • SCHONEWALD, Stephanie L.
  • SHINALL, Michael A.
  • SHORE, David E.
  • SMITH, Maria C.
  • SUBRAMANIAN, Sowmya
  • SUH, Su Kyung
  • TSE, Janet M.
  • VETTER, Michael L.
  • VRABLIK, Tracy L.
  • ZHANG, Jialan
Priority Data
62/938,24820.11.2019US
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE
(FR) MÉTHODES DE TRAITEMENT D'UNE MALADIE INFLAMMATOIRE DE L'INTESTIN
Abstract
(EN) The present disclosure provides methods for treating inflammatory bowel disease including Crohn's disease and ulcerative colitis by administering a compound of Formula (I) and pharmaceutically acceptable derivatives thereof, as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof.
(FR) La présente invention concerne des méthodes de traitement d'une maladie inflammatoire de l'intestin, notamment la maladie de Crohn et la recto-colite hémorragique, par l'administration d'un composé de formule (I) et de ses dérivés de qualité pharmaceutique, tels que décrits de façon générale et dans les catégories et sous-catégories de la description, et concerne en outre des compositions pharmaceutiques en comprenant.
Latest bibliographic data on file with the International Bureau